CEPH Forum Topics
- All Comments on CEPH
- General Discussion on CEPH
- Lowest P/E Ratios in the Nasdaq 100 [view article]
- Wall Street Breakfast: Must-Know News [view article]
- Fast Money Recap, 4/9/08: Airlines MayTake Off [view article]
- Pfizer Should Buy Amgen or Wyeth - Credit Suisse [view article]
- Jim Cramer's Stop Trading! Stock Picks and Comments, 9/6/07 [view article]
- Jim Cramer's Stop Trading! Stock Picks and Comments, April 23 [view article]
- One Page Barron's Summary [view article]
- Jim Cramer's Mad Money Lightning Round Picks 4/21 [view article]
Recent CEPH Articles
- Lowest P/E Ratios in the Nasdaq 100
- Wall Street Breakfast: Must-Know News
- Fast Money Recap, 4/9/08: Airlines MayTake Off
- Cephalon’s New CLL Drug Should Please Patients and Investors
- Pfizer Should Buy Amgen or Wyeth - Credit Suisse
- Under The Radar News - Wednesday
- Wall Street Breakfast: Must-Know News
- Nasdaq 100 Highest, Lowest Short Interest As a Percent of Float
- The Patent System and the High Price of Cephalon's Arsenic Treatment
- Loeb's Third Point Issues Latest 13F: Summary of Holdings
- Full List of Articles »
loading ...
Lowest P/E Ratios in the Nasdaq 100 [view article]
PETM looking good to me. No one ever seems to cut back on their dog's food and toys. ReplyLowest P/E Ratios in the Nasdaq 100 [view article]
Hello Big:Is there a reason for the pullback in NVDA? The valuations appears quite reasonable. Reply
Lowest P/E Ratios in the Nasdaq 100 [view article]
This chart would be even more useful if it also included trailing PEs. ReplyLowest P/E Ratios in the Nasdaq 100 [view article]
The problem with GRMN is that all of their functionalities can and will be imported into or imbedded into cell phones. Unless GRMN plans on getting into telecom they have a bleak future. Maybe they can develop some code or apps for the i-phone and forestall the inevitable. ReplyWall Street Breakfast: Must-Know News [view article]
Correcting a myth - regarding GM and Toyota Motor (TM).Many believe that GM is no. 1 globally as recently published it outsold Toyota by 1000 or 3000 cars in 2007.
In reality, GM's revenue was $181B in 2007 (01/2007-12/2007) down considerably on YOY. Toyota's revenue was $252B in FY2007 (04/2007-03/2008) up nearly 10%.
It is high time the U.S. auto industry started dealing with the harsh reality before it is too late. Hype and spin can go just so far...
CrossProfit Reply
Netratings
Wall Street Breakfast: Must-Know News [view article]
Wow - even we are impressed with comScore's numbers! Good job comScore! ReplyWall Street Breakfast: Must-Know News [view article]
I'm really liking the earnings reports tacked onto the Wall Street Breakfast. Thanks. ReplyEli Hoffmann
Wall Street Breakfast: Must-Know News [view article]
Thanks. Fixed. ReplyWall Street Breakfast: Must-Know News [view article]
Market climbed in Asia Friday. Nikkei +20.5% to 14,049. Is +20.5% a typo? ReplyFast Money Recap, 4/9/08: Airlines MayTake Off [view article]
Anyone who not only watches this slimiest group of touts/thieves/liars, but actually follows their recommendations, deserves to lose money.CNBC reached down into a toilet and came up with this group.
As if Cramer wasn't bad enough, this den of thieves makes Cramer look sainted.
Reply
Editors
General Discussion on CEPH
Is this a buy or a sell? Replypharma
Pfizer Should Buy Amgen or Wyeth - Credit Suisse [view article]
do a bunch of small deals would be my option for Pfe! Pharma is changing away from mega deals like the Lipitor Deal they did several years ago. Reason being is Competition in a MC World. In a MC world formulary control becomes the driver.No one pays for a med w/ o proven benefit "Outcomes" in our Brave New World! So you mine for selected Targeted Therapies that you can adroitly market. I see this as the new Pharma paradigm. Watch Pfe buy the Mid Sized biotech who is completing Phase-3 and is before FDA pending approval on 1 or 2 candidates w/ 1 already on the market in an area that is compatible w/ their Marketing/Research ReplyJim Cramer's Stop Trading! Stock Picks and Comments, 9/6/07 [view article]
THANKS, LOOKING FORWARD TO YOUR EMAILS ReplyJim Cramer's Stop Trading! Stock Picks and Comments, April 23 [view article]
Cramer called AZN's acquisition of MEDI a "classic overpay" and may make CELG and CEPH seem undervalued.What a minute, I thought Cramer said 5x's for a month including last week when he intervied NSTK ceo quay, that'nstk' has everything going for them".
Isn't NSTK undervalued too besides celg and ceph?
I mean didn't you see the volume the very next day on 'nstk' look at the charts!
Look at the nstk message board too. Last january you had 4 posters, now there are dozens because of Cramer. Hail Cramer!
HE SURE PICKED A WINNER WHEN HE SELECTED 'NSTK'. WHAT A COMPANY! Reply